-
Energy costs spark inflation surges in France, Italy
-
Ocon to leave Haas at end of F1 season
-
South Korea break China hearts to reach Asian Games football final
-
Indonesia razes poolside prison 'villas' where whisky, TVs seized
-
Eala storms into Asian Games semi-finals to thrill adoring fans
-
Japan court rules human voice is protected in TikTok AI case
-
Turkey freezes ex-minister's assets as fund crisis grows
-
French inflation jumps to 3% in September on energy costs
-
What we know about the North Korean POW dispute
-
South Korea score late to reach Asian Games football final
-
Most equities rise after oil price plunge, US data in focus
-
Tom Kim defies jet-lag, Kho cards ace as Asian Games golf begins
-
Polar oceans transformed as warming melts ice habitats: research
-
Thai teen rocker Nene aims to tour, write music... and return to school
-
Lost shark becomes viral star in South Korea
-
Ivory Coast clamps down on harmful illegal gold rush
-
Dangote to launch $16bn refinery in Kenya
-
Nagoya mayor says sorry for Asian Games 'inconveniences'
-
North Korean leader 'extremely obese': Seoul spy agency
-
G20 trade officials meet under shadow of tariffs, overcapacity
-
Yankees and pope-backed White Sox start MLB playoffs with wins
-
India's fat dog vote goes viral
-
Malaysia's ex-PM Mahathir in hospital for observation
-
Asian Games crowds in spotlight as 998 see hosts in 50,000 stadium
-
'No limits': Marathon world record holder Sawe chasing history
-
The eight stadiums for the 2027 Rugby World Cup
-
Countdown begins to biggest-ever Rugby World Cup
-
Thieves swipe drugs under nose of Fiji police, swap with flour
-
Bangladesh women lose ground after quota reform
-
South Korea demands North apologise for DMZ mine blasts
-
Vietnam admits 'differing opinions' on Hanoi development
-
In Nepal's flood zone, teachers mourn students who never returned
-
Stocks temper gains as oil pares heavy losses, US data in focus
-
US Supreme Court lifts limits on third-country deportations
-
New Zealand denies breaching climate commitments to EU
-
Antonelli eager to 're-establish order' as F1 returns to Malaysia
-
Albert becomes youngest US scorer in 4-2 win over Chile
-
Paw-fect candidate: Australia finds new koala rescue dog
-
Pirate island's plunging population shows Greece's demographic decline
-
One third of world population exposed to harmful air pollution: monitor
-
With elections ahead, Latvia's Russian-speakers reject Moscow's help
-
North Korea denies South's claim it was apparently behind DMZ mine blasts
-
Brazil football clubs face massive sponsorship blow from betting ban
-
West Bank's violent settlers part of a new generation fuelled by ideology
-
ChatGPT maker wants to be the App Store for AI as safety concerns grow
-
US-led coalition ends mission in Iraq
-
Women fight fires and sexism in Indonesian Borneo
-
Pope-backed White Sox join Braves with MLB playoff wins
-
Forsling's OT blast lifts Florida over Carolina in NHL opener
-
Guardian Metal Resources PLC Announces Total Voting Rights
French inventor of abortion pill calls Wyoming ban 'scandalous'
French scientist Etienne-Emile Baulieu, known as the father of the abortion pill, said it was "scandalous" and "a setback for women's freedom" that the US state of Wyoming has banned the drug.
Baulieu, who at the age of 96 is still working on treatments for depression and Alzheimer's, did not mince his words about the ban.
"It is a setback for women's freedom, particularly for those in the most precarious position who do not have the means to go to another state" to get an abortion, he told AFP in an interview.
Last week Wyoming became the first US state to outlaw the use of the abortion pill.
It was the latest point marked for conservative anti-abortion activists in the United States after the Supreme Court overturned the constitutional right to the procedure last year, leaving the policy to individual states.
Baulieu said he had dedicated a large part of his life to "increasing the freedom of women," and the ban was a step in the opposite direction.
Born in Strasbourg in 1926 to Jewish parents, Baulieu was raised by his feminist mother after his father, a doctor, died when he was a boy. At the age of 15, Baulieu joined the French resistance against Nazi occupation.
He went on to become a self-described "doctor who does science," specialising in the field of steroid hormones.
Invited to work in the United States, Baulieu was noticed in 1961 by Gregory Pincus, known as the father of the contraceptive pill, who convinced him to focus on sex hormones.
Back in France, Baulieu designed a way to block the effect of the hormone progesterone, which is essential for the egg to implant in the uterus after fertilisation.
"I wanted to make a contragestive," which stops gestation, he told AFP.
Partnering with the French Roussel-Uclaf laboratory, the oral drug RU-486, also known as mifepristone, was developed in 1982, providing a safe and inexpensive alternative to surgical abortion.
But there was a long battle for the drug to become authorised in the United States, where anti-abortion activists dubbed it the "death pill".
- 'Fanaticism and ignorance' -
In early March, French President Emmanuel Macron praised Baulieu's resilience when he presented the scientist with the Grand-Croix de la Legion d'Honneur, the top rank in France's honours system.
"You, a Jew and a resistance fighter, you were overwhelmed with the most atrocious insults and even compared to Nazi scientists," Macron said.
"But you held on, for the love of freedom and science."
Baulieu's wife Simone Harari Baulieu, a media producer in France, said "adversity slides off him like water off a duck's back".
She added that the recent "step backwards" in the United States was propelled by "fanaticism and ignorance".
Even at age 96, Baulieu heads into his office at the Kremlin-Bicetre University Hospital in the southern suburbs of Paris three times a week.
Stacks of photos, diplomas and binders contain "the work of a lifetime," the scientist said, adding that he still wants to "be useful".
His latest award is pinned to his blue suit, but Baulieu said he "never seriously hoped to receive such honours".
"It was a pleasure, but what interests me is improving people's health."
- 'Driving force' -
The team in his lab are continuing research he began years ago aiming to prevent the development of Alzheimer's disease, as well as treatment for severe depression, for which clinical trials begin in the coming months.
Baulieu said "there is no reason we cannot find treatments" for both illnesses, which have stubbornly evaded many previous attempts.
Julien Giustiniani, the team leader at the Baulieu Institute, which was created to finance research into dementia, said Baulieu was "always enthusiastic".
"He is a driving force for us," Giustiniani said.
Though Baulieu now uses a cane to walk, he exudes a tireless energy.
He partly credits using DHEA, a natural hormone produced by the adrenal gland, which Baulieu first described in the 1960s and has been touted as an anti-ageing supplement.
The causes that have dominated his life were "women, brain health and longevity," Baulieu said.
"I would be bored if I did not work anymore," he added.
G.P.Martin--AT